AIM ImmunoTech: Ownership Filing Amendment
Ticker: AIM · Form: SC 13D/A · Filed: Aug 14, 2024 · CIK: 946644
| Field | Detail |
|---|---|
| Company | Aim Immunotech INC. (AIM) |
| Form Type | SC 13D/A |
| Filed Date | Aug 14, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-filing, sec-filing, amendment
Related Tickers: AIM
TL;DR
Kellner & Deutsch updated their AIM ImmunoTech stake filing - check for ownership changes.
AI Summary
On August 12, 2024, Todd Deutsch and Ted D. Kellner filed an amendment (No. 6) to their Schedule 13D regarding AIM ImmunoTech Inc. The filing indicates a change in the reporting persons' beneficial ownership of the company's common stock. The specific details of the change in ownership percentage or number of shares are not explicitly stated in this excerpt, but the filing is an update to their previous disclosures.
Why It Matters
This filing signals a potential shift in the control or influence of significant shareholders in AIM ImmunoTech Inc., which could impact the company's strategic direction and stock performance.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant shareholder activity, which can lead to volatility and strategic shifts within the company.
Key Numbers
- August 12, 2024 — Filing Date (Date of the event requiring this filing)
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Subject Company
- Ted D. Kellner (person) — Reporting Person
- Todd Deutsch (person) — Reporting Person
- Baker & Hostetler LLP (company) — Legal Counsel
- John J. Harrington (person) — Contact Person
FAQ
What specific changes in beneficial ownership are reported in this amendment?
This excerpt does not detail the specific changes in beneficial ownership, only that an amendment (No. 6) to Schedule 13D has been filed by Todd Deutsch and Ted D. Kellner.
Who are the primary individuals filing this amendment?
The primary individuals filing this amendment are Todd Deutsch and Ted D. Kellner.
What is the CUSIP number for AIM ImmunoTech Inc. common stock?
The CUSIP number for AIM ImmunoTech Inc. common stock is 00901B105.
What is the business address of AIM ImmunoTech Inc.?
The business address of AIM ImmunoTech Inc. is 2117 SW HIGHWAY 484, OCALA, FL 32801.
What was the former name of AIM ImmunoTech Inc.?
The former name of AIM ImmunoTech Inc. was HEMISPHERX BIOPHARMA INC, with a date of name change on June 14, 1995.
Filing Stats: 849 words · 3 min read · ~3 pages · Grade level 7.5 · Accepted 2024-08-14 07:37:57
Key Financial Figures
- $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
Filing Documents
- d886473dsc13da.htm (SC 13D/A) — 37KB
- 0001193125-24-200241.txt ( ) — 39KB
is hereby supplemented as follows
Item 4 is hereby supplemented as follows: Mr. Kellner plans to submit to the Company notice (the Notice) of his intent to nominate himself, Mr. Deutsch and Mr. Chioini for election to the Companys board of directors at the 2024 annual meeting of stockholders. Mr. Kellner intends to submit the Notice well in advance of the deadline of September 13, 2024 set forth in the Companys bylaws, as amended on July 31, 2024. The Reporting Persons also continue to review legal options that may be available to them as a result of the boards improper purpose and breach of the duty of loyalty (as found by the Delaware Supreme Court with respect to the Companys 2023 bylaw amendments, and which the Reporting Persons believe have self-evidently continued thereafter).
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: August 14, 2024 TODD DEUTSCH By: /s/ Todd Deutsch TED D. KELLNER By: /s/ Ted D. Kellner